Unlock instant, AI-driven research and patent intelligence for your innovation.

Klebsiella pneumoniae (Mannose-sensitive hemagglutination) pilus strain

A Klebsiella, mannose technology, applied in bacteria, microorganisms, biochemical equipment and methods, etc., can solve problems such as no medical application value

Active Publication Date: 2013-05-29
BEIJING WONDER BIOPHARMACEUTICAL CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] The Klebsiella pneumoniae recorded in the prior art is a pathogenic bacterium and has no medical application value; there is no report that Klebsiella pneumoniae is used to prepare a vaccine at present

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Klebsiella pneumoniae (Mannose-sensitive hemagglutination) pilus strain
  • Klebsiella pneumoniae (Mannose-sensitive hemagglutination) pilus strain

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] Example 1. Source and identification of Klebsiella pneumoniae mannose-sensitive hemagglutination strains

[0059] The present inventor is by separating 6 strains of Klebsiella pneumoniae from clinical specimens, referring to (Muchia, the establishment of Pseudomonas aeruginosa mannose-sensitive hemagglutination pili strain, Acta Microbiology, 26 (2): 176-179 , 1986), screening and breeding were carried out to obtain a Klebsiella pneumoniae mannose-sensitive hemagglutination strain.

[0060] The main identifying features are as follows:

[0061] Colored colonies appear when lactose is fermented on differential media;

[0062] On the solid medium, gray-white sticky peptone-like colonies;

[0063] After several days of incubation in broth, the liquid becomes noticeably viscous;

[0064] Gram negative.

[0065] Electron micrographs were carried out on this strain, as shown in figure 1 Shown, showing the presence of peripilie. Mannose-sensitive hemagglutination and hem...

Embodiment 2

[0066] Embodiment 2. Bacterial strain culture and bacterial vaccine preparation

[0067] The Klebsiella pneumoniae mannose-sensitive hemagglutination pili strain of the present invention was cultivated on a bacterial plate at 37°C for 18 hours, the culture was collected, sterilized with formaldehyde solution, washed repeatedly to make a dead bacterin vaccine, diluted with sterile Bacteria physiological saline, adding 1% benzyl alcohol as a preservative to prepare the bacterin.

Embodiment 3

[0068] Embodiment 3. Animal experiment of bacterin

[0069] Use bacterial plate culture, 1% formaldehyde saline to kill bacteria, wash 5 times with sterile normal saline, spectrophotometer to detect the concentration of bacteria solution, and then check whether there are live bacteria, dilute to 1.8 to 2 billion / ml, and make bacteria Seedling.

[0070] The experimental animals used in the animal experiments are small white mice with a weight of 18-20 grams. Subcutaneous injection 3 times, each injection 0.3ml. The interval between injections was one week. Seven days after the last injection, the cross-agglutination MSHA antibody titer of the immunized mice was detected.

[0071] Table 1. After the mouse is immunized with the "bacterin" of the present invention, the cross-agglutination titer detection of the antibody in its blood and the MSHA antigen of two kinds of bacteria

[0072]

[0073] Immune protection test A total of 43 mice were immunized successively. After 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a klebsiella pneumoniae mannose-sensitive hemagglutination pilus strain which is characterized by comprising mannose-sensitive hemagglutination pilus. The invention also relates to the cultivation, treatment, application and using method of the klebsiella pneumoniae mannose-sensitive hemagglutination pilus strain. The invention also relates to a medical product prepared by the klebsiella pneumoniae mannose-sensitive hemagglutination pilus strain.

Description

technical field [0001] The present invention relates to a novel microbial strain. Specifically, the present invention relates to a Klebsiella pneumoniae mannose-sensitive hemagglutination pili strain. The invention also relates to the cultivation, treatment, use and methods of use of this Klebsiella pneumoniae strain. The invention also relates to a medical product prepared by using the Klebsiella pneumoniae strain. Background technique [0002] Klebsiella (Klebsiella) is currently the most important conditional pathogenic bacteria except Escherichia coli, and its biochemical reactions are very similar to those of Serratia, Enterobacter, and Hafnia. Some amino acid decarboxylase tests have help in identification. [0003] The genus Klebsiella can be divided into five species, namely Klebsiella pneumoniae (K. pneumoniae), Klebsiella oxytoca (R. ornithinolytica), K. planticola and K. terrigena. Among them, Klebsiella pneumoniae can be divided into three subspecies: subsp....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N1/21C12R1/22
Inventor 牟希亚郭雁群牟心赤朱洁
Owner BEIJING WONDER BIOPHARMACEUTICAL CO LTD